Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level

FEBS Letters

Volumn 580, Issue 25, 2006, Pages 5925-5933

  Sengupta, Amitabha ^a   Novak, Michal ^b   Grundke Iqbal, Inge ^a   Iqbal, Khalid ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

Author keywords

Alzheimer disease; Cyclin dependent protein kinase 5; Glycogen synthase kinase 3; Neurofibrillary degeneration; Tau hyperphosphorylation; Tau kinases

Indexed keywords

CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3; ISOPROTEIN; SERINE; TAU PROTEIN; THREONINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CHEMICAL ANALYSIS; DISSOCIATION; ENZYME SUBSTRATE; HUMAN; MICROTUBULE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION;

ANIMALS; BINDING SITES; BRAIN; CYCLIN-DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICROTUBULES; PHOSPHORYLATION; PROTEIN ISOFORMS; RATS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TAU PROTEINS;

EID: 33750072653     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.09.060     Document Type: Article

References (44)

1. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83 (1986) 4913-4917
2. Alonso A., Zaidi T., Grundke-Iqbal I., and Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91 (1994) 5562-5566
3. Alonso A., Grundke-Iqbal I., Barra H.S., and Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc. Natl. Acad. Sci. USA 94 (1997) 298-303
4. Alonso Adel C., Li B., Grundke-Iqbal I., and Iqbal K. Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity. Proc. Natl. Acad. Sci. USA 103 (2006) 8864-8869
5. Wang J.Z., Gong C.X., Zaidi T., Grundke-Iqbal I., and Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J. Biol. Chem. 270 (1995) 4854-4860
6. Wang J.Z., Grundke-Iqbal I., and Iqbal K. Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res. Mol. Brain Res. 38 (1996) 200-208
7. Hanger D.P., Betts J.C., Loviny T.L., Blackstock W.P., and Anderton B.H. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J. Neurochem. 71 (1998) 2465-2476
8. Iqbal K., Alonso Adel C., Chen S., Chohan M.O., El-Akkad E., Gong C.X., Khatoon S., Li B., Liu F., Rahman A., Tanimukai H., and Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 1739 (2005) 198-210
9. Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C.A., and Imahori K. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol. (Berl). 92 (1996) 232-241
10. Pei J.J., Tanaka T., Tung Y.C., Braak E., Iqbal K., and Grundke-Iqbal I. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 56 (1997) 70-78
11. Pei J.J., Grundke-Iqbal I., Iqbal K., Bogdanovic N., Winblad B., and Cowburn R.F. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res. 797 (1998) 267-277
12. Pei J.J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., and Cowburn R.F. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 58 (1999) 1010-1019
13. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., and Tsai L.H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40 (2003) 471-483
14. Engel T., Hernandez F., Avila J., and Lucas J.J. Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J. Neurosci. 26 (2006) 5083-5090
15. Cho J.H., and Johnson G.V. Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules. J. Neurochem. 88 (2004) 349-358
16. Sengupta A., Kabat J., Novak M., Wu Q., Grundke-Iqbal I., and Iqbal K. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch. Biochem. Biophys. 357 (1998) 299-309
17. Li T., Hawkes C., Qureshi H.Y., Kar S., and Paudel H.K. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta. Biochemistry 45 (2006) 3134-3145
18. Plattner F., Angelo M., and Giese K.P. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J. Biol. Chem. 281 (2006) 25457-25465
19. Goedert M., Spillantini M.G., Jakes R., Rutherford D., and Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3 (1989) 519-526
20. Hasegawa M., Watanabe A., Takio K., Suzuki M., Arai T., Titani K., and Ihara Y. Characterization of two distinct monoclonal antibodies to paired helical filaments: further evidence for fetal-type phosphorylation of the tau in paired helical filaments. J. Neurochem. 60 (1993) 2068-2077
21. Seubert P., Mawal-Dewan M., Barbour R., Jakes R., Goedert M., Johnson G.V., Litersky J.M., Schenk D., Lieberburg I., Trojanowski J.Q., et al. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J. Biol. Chem. 270 (1995) 18917-18922
22. Greenberg S.G., and Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87 (1990) 5827-5831
23. Grundke-Iqbal I., Vorbrodt A.W., Iqbal K., Tung Y.C., Wang G.P., and Wisniewski H.M. Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments. Brain Res. 464 (1988) 43-52
24. Iqbal K., Grundke-Iqbal I., Smith A.J., George L., Tung Y.C., and Zaidi T. Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc. Natl. Acad. Sci. USA 86 (1989) 5646-5650
25. Tanaka T., Zhong J., Iqbal K., Trenkner E., and Grundke-Iqbal I. The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatases. FEBS Lett. 426 (1998) 248-254
26. Singh T.J., Haque N., Grundke-Iqbal I., and Iqbal K. Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3. FEBS Lett. 358 (1995) 267-272
27. Qi Z., Huang Q.Q., Lee K.Y., Lew J., and Wang J.H. Reconstitution of neuronal Cdc2-like kinase from bacteria-expressed Cdk5 and an active fragment of the brain-specific activator. Kinase activation in the absence of Cdk5 phosphorylation. J. Biol. Chem. 270 (1995) 10847-10854
28. Sengupta A., Wu Q., Grundke-Iqbal I., Iqbal K., and Singh T.J. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol. Cell. Biochem. 167 (1997) 99-105
29. Singh T.J., Wang J.Z., Novak M., Kontzekova E., Grundke-Iqbal I., and Iqbal K. Calcium/calmodulin-dependent protein kinase II phosphorylates tau at Ser-262 but only partially inhibits its binding to microtubules. FEBS Lett. 387 (1996) 145-148
30. Taniguchi S., Fujita Y., Hayashi S., Kakita A., Takahashi H., Murayama S., Saido T.C., Hisanaga S., Iwatsubo T., and Hasegawa M. Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett. 489 (2001) 46-50
31. Paudel H.K., Lew J., Ali Z., and Wang J.H. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J. Biol. Chem. 268 (1993) 23512-23518
32. Yang S.D., Yu J.S., Shiah S.G., and Huang J.J. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain. J. Neurochem. 63 (1994) 1416-1425
33. Song J.S., and Yang S.D. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain. J. Protein. Chem. 14 (1995) 95-105
34. Moreno F.J., Medina M., Perez M., Montejo de Garcini E., and Avila J. Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin). FEBS Lett. 372 (1995) 65-68
35. Godemann R., Biernat J., Mandelkow E., and Mandelkow E.M. Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain. FEBS Lett. 454 (1999) 157-164
36. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Titani K., and Ihara Y. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270 (1995) 823-829
37. Arioka M., Tsukamoto M., Ishiguro K., Kato R., Sato K., Imahori K., and Uchida T. Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein. J. Neurochem. 60 (1993) 461-468
38. Singh T.J., Grundke-Iqbal I., and Iqbal K. Differential phosphorylation of human tau isoforms containing three repeats by several protein kinases. Arch. Biochem. Biophys. 328 (1996) 43-50
39. Alonso A., Zaidi T., Novak M., Barra H.S., Grundke-Iqbal I., and Iqbal K. Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J. Biol. Chem. 276 (2001) 37967-37973
40. Alonso A., Zaidi T., Novak M., Grundke-Iqbal I., and Iqbal K. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. USA 98 (2001) 6923-6928
41. Drewes G., Trinczek B., Illenberger S., Biernat J., Schmitt-Ulms G., Meyer H.E., Mandelkow E.M., and Mandelkow E. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J. Biol. Chem. 270 (1995) 7679-7688
42. Goode B.L., Denis P.E., Panda D., Radeke M.J., Miller H.P., Wilson L., and Feinstein S.C. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly. Mol. Biol. Cell. 8 (1997) 353-365
43. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., and Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10 (1993) 1089-1099
44. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., and Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43 (1998) 815-825